G
Market Data
$2.13+$0.05 (+2.40%)
GRCE · Last trade
Prev Close
$2.08
Range (28d)
$2.07 – $2.20
Recent Filings
- SCHEDULE 13G/A13.7 KBGrace Therapeutics, Inc.Aug 14, 5:03 PM ET·0001104659-26-097338
- SCHEDULE 13G/A11.2 KBGrace Therapeutics, Inc.Aug 14, 4:44 PM ET·0001104659-26-097290
- 8-K312.6 KBGrace Therapeutics, Inc.Aug 13, 8:01 AM ET·0001140361-26-032644
- 10-Q4.4 MBGrace Therapeutics, Inc.Aug 13, 7:30 AM ET·0001140361-26-032632
- SCHEDULE 13G23.3 KBGrace Therapeutics, Inc.Aug 7, 4:05 PM ET·0001493152-26-036565
- 8-K696.2 KBGrace Therapeutics, Inc.Aug 6, 4:06 PM ET·0001140361-26-031671
- 8-K6.8 MBGrace Therapeutics, Inc.Jul 28, 7:16 AM ET·0001140361-26-029837
- 8-K6.8 MBGrace Therapeutics, Inc.Jun 18, 8:15 AM ET·0001140361-26-025669
- 8-K333.3 KBGrace Therapeutics, Inc.Jun 18, 8:01 AM ET·0001140361-26-025667
- 10-K15.2 MBGrace Therapeutics, Inc.Jun 18, 7:31 AM ET·0001140361-26-025662
Insiders
10- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Boily Jean-FrancoisVICE-PRESIDENT, FINANCE
- Canan JohnDirector
- Carter Roderick NoelDirector
- D'Alvise JanelleDirector, PRESIDENT & CEO
- D'Andrea CarrieVP Clinical Operations
- DAVIS A BRIANDirector
- DelAversano Robert JPrincipal Financial Officer
- Derby MichaelDirector
Tickers
Addresses
business
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
mailing
103 CARNEGIE CENTER SUITE 300
PRINCETON, NJ, 08540
Former Names
- Acasti Pharma Inc.2024-10-25